CA2009074A1 - Ameliorations concernant les derives de guanidine - Google Patents

Ameliorations concernant les derives de guanidine

Info

Publication number
CA2009074A1
CA2009074A1 CA2009074A CA2009074A CA2009074A1 CA 2009074 A1 CA2009074 A1 CA 2009074A1 CA 2009074 A CA2009074 A CA 2009074A CA 2009074 A CA2009074 A CA 2009074A CA 2009074 A1 CA2009074 A1 CA 2009074A1
Authority
CA
Canada
Prior art keywords
relating
guanidine derivatives
compound
trimethylpropylguanidine
isomer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2009074A
Other languages
English (en)
Other versions
CA2009074C (fr
Inventor
David Wayne Robertson
Mitchell Irvin Steinberg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2009074A1 publication Critical patent/CA2009074A1/fr
Application granted granted Critical
Publication of CA2009074C publication Critical patent/CA2009074C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/04—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA002009074A 1989-02-03 1990-02-01 Ameliorations concernant les derives de guanidine Expired - Fee Related CA2009074C (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US30671489A 1989-02-03 1989-02-03
US07/306,714 1989-02-03

Publications (2)

Publication Number Publication Date
CA2009074A1 true CA2009074A1 (fr) 1990-08-03
CA2009074C CA2009074C (fr) 1999-07-27

Family

ID=23186533

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002009074A Expired - Fee Related CA2009074C (fr) 1989-02-03 1990-02-01 Ameliorations concernant les derives de guanidine

Country Status (13)

Country Link
EP (1) EP0381504A3 (fr)
JP (1) JP2823631B2 (fr)
KR (1) KR100220989B1 (fr)
CN (1) CN1043527C (fr)
AU (1) AU623217B2 (fr)
CA (1) CA2009074C (fr)
HU (1) HU208959B (fr)
IE (1) IE900391L (fr)
IL (1) IL93252A0 (fr)
MX (1) MX170706B (fr)
NZ (1) NZ232336A (fr)
PT (1) PT93033B (fr)
ZA (1) ZA90772B (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ229828A (en) * 1988-08-09 1992-03-26 Squibb & Sons Inc Aryl cyanoguanidine derivatives and pharmaceutical compositions
JPH05294935A (ja) * 1991-03-15 1993-11-09 Green Cross Corp:The アミノピリジン系化合物
US5371086A (en) * 1991-03-15 1994-12-06 The Green Cross Corporation Aminopyridine compounds
AU4530693A (en) * 1992-08-13 1994-03-15 Upjohn Company, The Cyanoguanidines as potassium channel blockers
GB9219472D0 (en) * 1992-09-15 1992-10-28 Leo Pharm Prod Ltd Chemical compounds
JPH08511264A (ja) * 1993-06-11 1996-11-26 ジ・アップジョン・カンパニー K−チャンネル遮断剤としてのピリミジン,シアノグアニジン
EP0956866A1 (fr) * 1996-12-26 1999-11-17 Kirin Beer Kabushiki Kaisha Medicaments pour soigner les troubles de la circulation ophtalmiques
FR2760838B1 (fr) * 1997-03-13 1999-05-21 Corning Inc Circuit fluidique integre d'execution d'un processus de preparation ou d'analyse d'un echantillon de matiere fluide, son procede de fabrication et appareil d'exploitation de ce circuit
US6645968B2 (en) 1999-08-03 2003-11-11 Abbott Laboratories Potassium channel openers
MXPA02001207A (es) * 1999-08-03 2002-07-30 Abbott Lab Abridores de canal de potasio.
CN105580233B (zh) * 2013-09-27 2018-05-29 三菱电机株式会社 功率转换装置
JP7437932B2 (ja) * 2019-12-27 2024-02-26 三井化学株式会社 廃水処理方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1489879A (en) * 1974-12-20 1977-10-26 Leo Pharm Prod Ltd N'-cyano-n'-3-pyridylguanidines
FR2624699B1 (fr) * 1987-12-18 1990-04-13 Bernard Lyon I Universite Clau Derives heterocycliques de n-carbamoyl-, n-thiocarbamoyl- ou n-amidino-glycine ou beta-alanine utiles comme agents edulcorants

Also Published As

Publication number Publication date
ZA90772B (en) 1991-10-30
PT93033B (pt) 1996-03-29
EP0381504A2 (fr) 1990-08-08
HUT53876A (en) 1990-12-28
HU900641D0 (en) 1990-04-28
KR100220989B1 (ko) 1999-09-15
CA2009074C (fr) 1999-07-27
AU623217B2 (en) 1992-05-07
AU4897790A (en) 1990-08-09
HU208959B (en) 1994-02-28
CN1043527C (zh) 1999-06-02
IE900391L (en) 1990-08-03
CN1044654A (zh) 1990-08-15
IL93252A0 (en) 1990-11-29
MX170706B (es) 1993-09-08
EP0381504A3 (fr) 1991-09-04
KR900012897A (ko) 1990-09-03
NZ232336A (en) 1991-07-26
JPH02235868A (ja) 1990-09-18
PT93033A (pt) 1990-11-07
JP2823631B2 (ja) 1998-11-11

Similar Documents

Publication Publication Date Title
CA2048110A1 (fr) Derives d'imidazopyridine et leur utilisation
LV10949A (lv) Aizvietoti 4-fenil-4piperidinkarboksamidi to iegusanas panemiens farmaceitiska kompozicija
CA2194885A1 (fr) Benzamidines substituees, leur preparation et leur utilisation comme medicaments
IT1182199B (it) Procedimento per la preparazione di composti 1,3-diossolan-4-metanolici otticamente attivi
AU6644986A (en) S-(-)-1-propyl-2', 6' pipecoloxylidide hydrochloride monohydrate and a method for its preparation
EP0381504A3 (fr) Dérivés de guanidine
EP0138344A3 (fr) Pyridazinones utiles comme beta-adrenorecepteurs antagonistes
IT1146940B (it) Composti 2,4-diamminopirido (2,3-d) pirimidinici dotati di attivita' farmacologica e procedimento per la loro preparazione
ES2045067T3 (es) Procedimiento para preparar nuevos compuestos de tiazol.
IT8922246A0 (it) Procedimento di preparazione di 3-ciano-3,5,5'-trimetil-1-cicloesanone
IT1190604B (it) Procedimento per la preparazione di 4,4-dialchil-2-azetidinoni
IT1215344B (it) Procedimento per la preparazione di composti ad attivita' anti-ulcera.
IT8123546A0 (it) Composto ad attivita' antiulcera, procedimento per la sua preparazione e composizioni farmaceutiche relative
IT8622780A0 (it) "2-cloro-12-(-3-dimetilammino-2-metilpropil)-12h-dibenzo-/d,g//1,3,6/d iossazocine otticamente attive eprocedimento per la loro preparazione.
GR3002884T3 (en) Substituted chinoxalyl-imidazolidine-2,4-diones, process for their preparation, their use as medicaments and pharmacological preparations
CA2027530A1 (fr) Composes w-phenoxy-heterocycliques
IT1237531B (it) Procedimento perfezionato per la preparazione di poli(2,6-dimetil-p- ossifenilene) modificato
ES547054A0 (es) Un procedimiento para la preparacion de un compuesto de 1,3 -diacil-2-oxindol
IL114866A0 (en) Process for the preparation of the (-)-n-methyl-n-Ú4-(4-phenyl-4-acetylaminopiperidin-1-yl-2-(3,4-dichlorophenyl) butyl¾ benzamide
IT1137375B (it) Composto ad attivita' vasodilatatrice periferica utile come rubefacente, procedimento per la sua preparazione e composizioni farmaceutiche a base di detto composto
DE3262231D1 (en) A novel vasodilator compound, process for the preparation thereof and pharmaceutical compositions thereform
IT1211027B (it) Pina procedimento per la preparazione di _ una pirido-[2,3-b][1,4]benzodiaze
IT8920136A0 (it) Procedimento per la preparazione della fenilidrazide dell'acido 2,2.bis(idrossimetil) propionico.
GT198400116A (es) Procedimiento para la elaboracion de n-12-[(dimetalimino)me-til]-2-furanil] metiltio-] etil-]-n'alquil -2-nitro-1,1 ete-nodiamina
IT8219901A0 (it) Composto ad attivita' antivirale, procedimento per la sua preparazione e relative composizioni farmaceutiche.

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed